#ExpertAnswers: Christopher Perry and Homira Osman on Integrating Patients, Clinical, and Advocacy Partners with Preclinical Research Labs
Dr. Christopher Perry, York University and Dr. Homira Osman, Muscular Dystrophy Canada answer questions from a recent webinar on how the integration of clinical, industrial, and not-for-profit advocacy partners with preclinical research labs offers great potential to improve our research impact.
Integrating Patient Engagement and Trainee Development in Pre-Clinical Research
Christopher Perry, PhD discusses how his laboratory aims to discover mechanisms by which metabolic dysfunction causes muscle weakness and apply these findings to develop new therapies for muscle disorders. Homira Osman, PhD provides a particular focus on leveraging scientific findings for practice and policy and linking trainees with patient communities.
Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation
In this webinar, Evidera experts present guidance on why strong connections with registry groups and stakeholder populations are important for generating relevant real-world evidence to advance treatments.
Minimizing the Impact of Cross-Cultural Differences in COA Translations
ICON's COA Linguistic Validation Leaders highlight the importance of Linguistic Validation and how equivalence should be a key focus during the development of Clinical Outcome Assessment translations.
Bruker Virtual NMR Users Meeting
The Bruker Users Meeting is an annual gathering of our NMR community and a chance to listen, learn, and share knowledge and ideas.